Skip to Content

ID 150 (Ibandronate Sodium 150 mg)

Pill with imprint ID 150 is Yellow, Capsule-shape and has been identified as Ibandronate Sodium 150 mg. It is supplied by Alvogen Inc.

Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ID 150

Ibandronate Sodium

Imprint
ID 150
Strength
150 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen Inc
National Drug Code (NDC)
47781-0103

Get help with Imprint Code FAQs.

Related Images for "ID 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.